Key Takeaway: Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced its participation in the 24th Annual Needham Healthcare Conference, scheduled for April 7-10, 2025. The company will engage in a fireside chat on April 8, 2025, at 9:30 a.m. ET, which will be available for live viewing on their website. Collegium aims to boost its portfolio, focusing on responsible pain management and ADHD treatment with Jornay PM.
Price reaction · baseline $29.85 (2025-03-31 close) · hit after-hours · clean, no other COLL news in the window
day 0 close · peak
-1.5%
Market Sentiment Analysis
POSITIVE FACTORS
Participation in a prominent healthcare conference can raise visibility.
Webcast offers accessibility and transparency for investors.
Company is expanding its portfolio with recently acquired ADHD treatment.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+28%
120-day peak, hindsight
Typical move
0.4%
average across 3 past catalysts
Lead asset
DFN-15 Active
Phase 3 · Migraine Headache
Full Press Release Details
STOUGHTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will participate in a fireside chat at the 24th Annual Needham Healthcare Conference being held virtually from April 7-10, 2025.
Details of the event are as follows:
Fireside Chat Date and Time: Tuesday, April 8, 2025, at 9:30 a.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM®, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Frequently Asked Questions
When is Collegium's fireside chat scheduled?
The fireside chat is on April 8, 2025, at 9:30 a.m. ET.
How can I access the live webcast of the chat?
The webcast can be accessed from the Investors section of Collegium's website.
Will there be a replay of the fireside chat?
Yes, a replay will be available for 90 days after the event.
What does Collegium Pharma focus on?
Collegium focuses on pain management and recently added ADHD treatment with Jornay PM.
Where is Collegium Pharmaceutical located?
Collegium's headquarters are in Stoughton, Massachusetts.